Placental growth factor and pre-eclampsia

Journal of Human Hypertension

Volumn 31, Issue 12, 2017, Pages 782-786

  Chau, K ^a,b,c   Hennessy, A ^a,c,d   Makris, A ^a,d,e,f  

^a HEART RESEARCH INSTITUTE   (Australia)

^b BLACKTOWN HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR; PRAVASTATIN;

ANGIOGENESIS; FEMALE; HUMAN; NONHUMAN; PATHOGENESIS; PLACENTA DEVELOPMENT; PREDICTION; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCTION; REVIEW; ANIMAL; BLOOD; PHYSIOLOGY;

ANIMALS; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA GROWTH FACTOR; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 85033221572     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2017.61     Document Type: Review

References (35)

1. Arad A, Nammouz S, Nov Y, Ohel G, Bejar J, Vadasz Z. The Expression of neuropilin-1 in human placentas from normal and preeclamptic pregnancies. Int J Gynecol Pathol 2016.
2. Gobble RM, Groesch KA, Chang M, Torry RJ, Torry DS. Differential regulation of human PlGF gene expression in trophoblast and nontrophoblast cells by oxygen tension. Placenta 2009; 30(10): 869-875.
3. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C et al. Hypoxia downregulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for 'placental hyperoxia' in intrauterine growth restriction. Lab Invest 1999; 79(2): 151-170.
4. Xu L, Cochran DM, Tong RT, Winkler F, Kashiwagi S, Jain RK et al. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res 2006; 66(8): 3971-3977.
5. Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, Schmidt T et al. Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 2010; 141(1): 178-190.
6. Lassen U, Chinot OL, McBain C, Mau-Sorensen M, Larsen VA, Barrie M et al. Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. Neuro Oncol 2015; 17(7): 1007-1015.
7. Binder NK, Evans J, Salamonsen LA, Gardner DK, Kaitu'u-Lino TJ, Hannan NJ. Placental growth factor is secreted by the human endometrium and has potential important functions during embryo development and implantation. PLoS ONE 2016; 11(10): e0163096.
8. Luna RL, Kay VR, Ratsep MT, Khalaj K, Bidarimath M, Peterson N et al. Placental growth factor deficiency is associated with impaired cerebral vascular development in mice. Mol Hum Reprod 2016; 22(2): 130-142.
9. Dang F, Croy BA, Stroman PW, Figueiro-Filho EA. Impacts of Preeclampsia on the Brain of the Offspring. Rev Bras Ginecol Obstet 2016; 38(8): 416-422.
10. Ratsep MT, Carmeliet P, Adams MA, Croy BA. Impact of placental growth factor deficiency on early mouse implant site angiogenesis. Placenta 2014; 35(9): 772-775.
11. Kang MC, Park SJ, Kim HJ, Lee J, Yu DH, Bae KB et al. Gestational loss and growth restriction by angiogenic defects in placental growth factor transgenic mice. Arterioscler Thromb Vasc Biol 2014; 34(10): 2276-2282.
12. Burke SD, Barrette VF, Bianco J, Thorne JG, Yamada AT, Pang SC et al. Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice. Hypertension 2010; 55(3): 729-737.
13. Athanassiades A, Lala PK. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998; 19(7): 465-473.
14. Knuth A, Liu L, Nielsen H, Merril D, Torry DS, Arroyo JA. Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells. Am J Reprod Immunol 2014; 73: 330-340.
15. Tayade C, Hilchie D, He H, Fang Y, Moons L, Carmeliet P et al. Genetic deletion of placenta growth factor in mice alters uterine NK cells. J Immunol 2007; 178(7): 4267-4275.
16. Arroyo J, Price M, Straszewski-Chavez S, Torry RJ, Mor G, Torry DS. XIAP protein is induced by placenta growth factor (PLGF) and decreased during preeclampsia in trophoblast cells. Syst Biol Reprod Med 2014; 60(5): 263-273.
17. Desai J, Holt-Shore V, Torry RJ, Caudle MR, Torry DS. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 1999; 60(4): 887-892.
18. Saffer C, Olson G, Boggess KA, Beyerlein R, Eubank C, Sibai BM. Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens 2013; 3(2): 124-132.
19. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7): 672-683.
20. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5): 649-658.
21. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008; 28(12): 1110-1115.
22. Hoeller A, Ehrlich L, Golic M, Herse F, Perschel FH, Siwetz M et al. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies. Hypertens Pregnancy 2017; 36(2): 151-160.
23. Mizuuchi M, Cindrova-Davies T, Olovsson M, Charnock-Jones DS, Burton GJ, Yung HW. Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6beta: implications for the pathophysiology of human pregnancy complications. J Pathol 2016; 238(4): 550-561.
24. Tudisco L, Della Ragione F, Tarallo V, Apicella I, D'Esposito M, Matarazzo MR et al. Epigenetic control of hypoxia inducible factor-1alpha-dependent expression of placental growth factor in hypoxic conditions. Epigenetics 2014; 9(4): 600-610.
25. Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, Bossuyt PM, van der Post JA, von Dadelszen P et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. Bjog 2012; 119(7): 778-787.
26. Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther 2013; 33(1): 16-27.
27. Park FJ, Leung CH, Poon LC, Williams PF, Rothwell SJ, Hyett JA. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol 2013; 53(6): 532-539.
28. Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol 2016; 214(1): 108 e1-108 e14.
29. Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 2013; 128(19): 2121-2131.
30. Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 2016; 27(3): 903-913.
31. Suzuki H, Ohkuchi A, Matsubara S, Takei Y, Murakami M, Shibuya M et al. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension 2009; 54(5): 1129-1135.
32. Spradley FT, Tan AY, Joo WS, Daniels G, Kussie P, Karumanchi SA et al. Placental growth factor administration abolishes placental ischemia-induced hypertension. Hypertension 2016; 67(4): 740-747.
33. Zhu M, Ren Z, Possomato-Vieira JS, Khalil RA. Restoring placental growth factorsoluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy. Am J Physiol Regul Integr Comp Physiol 2016; 311(3): R505-R521.
34. Makris A, Yeung KR, Lim SM, Sunderland N, Heffernan S, Thompson JF et al. Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates. Hypertension 2016; 73(4): 330-340.
35. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci USA 2011; 108(4): 1451-1455.